SCHEMBL7984496

SCHEMBL7984496

CCc1nc2ncn(Cc3cccc(N(C)C)c3)c2c(=O)[nH]1

nearest known ligand 0.45

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
HPGD P15428 1/20 0.45
SMN1; SMN2 Q16637 4/20 0.44
ALDH1A1 P00352 2/20 0.44
KMT2A Q03164 3/20 0.44
MET P08581 1/20 0.39
GAA P10253 1/20 0.38
BRD4 O60885 2/20 0.37
GRIN1 Q05586 1/20 0.37
GRIN2B Q13224 1/20 0.37
HTT P42858 2/20 0.35
GLA P06280 1/20 0.35
UBE2N P61088 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
MEN1 O00255 2/20 0.35
TP53 P04637 2/20 0.34
RXFP1 Q9HBX9 1/20 0.34
HSD17B10 Q99714 1/20 0.34
TNKS2 Q9H2K2 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7974255 0.86 HPGD (0.47) HPGDSMN1; SMN2ALDH1A1KMT2AGAA
SCHEMBL7984206 0.85 HPGD (0.46) HPGDSMN1; SMN2ALDH1A1KMT2AGAA
SCHEMBL7984753 0.85 SMN1; SMN2 (0.51) HPGDSMN1; SMN2ALDH1A1KMT2AGAA
SCHEMBL7975251 0.84 SMN1; SMN2 (0.60) HPGDSMN1; SMN2ALDH1A1KMT2AGAA
SCHEMBL7984500 0.83 CNOT7 (0.40) HPGDSMN1; SMN2ALDH1A1METGRIN1
SCHEMBL7984510 0.83 GAA (0.53) HPGDSMN1; SMN2ALDH1A1KMT2AGAA
SCHEMBL7985648 0.81 HPGD (0.47) HPGDSMN1; SMN2ALDH1A1KMT2AGAA
SCHEMBL7984374 0.79 HPGD (0.43) HPGDSMN1; SMN2ALDH1A1KMT2AGAA
SCHEMBL7987432 0.78 HPGD (0.47) HPGDSMN1; SMN2ALDH1A1KMT2ABRD4
SCHEMBL7973932 0.78 SMN1; SMN2 (0.53) HPGDSMN1; SMN2ALDH1A1KMT2AGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6310070-B1 FOR TREATING NEPHRITIS, IMPROVING PROTEINURIA DUE TO GLOMERULONEPHRITIS AND PREVENTING AGGRAVATION OF NEPHRITIS JAPAN ENERGY CORPORATION (JP) 2001-10-30 US disclosed
EP-0999211-A1 NOVEL PURINE DERIVATIVES AND MEDICINAL USE THEREOF JAPAN ENERGY CORPORATION (JP) 2000-05-10 EP disclosed